246 related articles for article (PubMed ID: 24059472)
1. Acute Rho-kinase inhibition improves coronary dysfunction in vivo, in the early diabetic microcirculation.
Pearson JT; Jenkins MJ; Edgley AJ; Sonobe T; Joshi M; Waddingham MT; Fujii Y; Schwenke DO; Tsuchimochi H; Yoshimoto M; Umetani K; Kelly DJ; Shirai M
Cardiovasc Diabetol; 2013 Aug; 12():111. PubMed ID: 24059472
[TBL] [Abstract][Full Text] [Related]
2. Chronic Rho-kinase inhibition improves left ventricular contractile dysfunction in early type-1 diabetes by increasing myosin cross-bridge extension.
Waddingham MT; Edgley AJ; Astolfo A; Inagaki T; Fujii Y; Du CK; Zhan DY; Tsuchimochi H; Yagi N; Kelly DJ; Shirai M; Pearson JT
Cardiovasc Diabetol; 2015 Jul; 14():92. PubMed ID: 26194354
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Rho kinase protects from ischaemia-reperfusion injury via regulation of arginase activity and nitric oxide synthase in type 1 diabetes.
Tratsiakovich Y; Kiss A; Gonon AT; Yang J; Sjöquist PO; Pernow J
Diab Vasc Dis Res; 2017 May; 14(3):236-245. PubMed ID: 28183205
[TBL] [Abstract][Full Text] [Related]
4. Fasudil ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats: a possible role of Rho kinase.
Hofni A; Shehata Messiha BA; Mangoura SA
Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):801-811. PubMed ID: 28493050
[TBL] [Abstract][Full Text] [Related]
5. Dynamic synchrotron imaging of diabetic rat coronary microcirculation in vivo.
Jenkins MJ; Edgley AJ; Sonobe T; Umetani K; Schwenke DO; Fujii Y; Brown RD; Kelly DJ; Shirai M; Pearson JT
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):370-7. PubMed ID: 22075246
[TBL] [Abstract][Full Text] [Related]
6. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
[TBL] [Abstract][Full Text] [Related]
7. The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling.
Lai D; Gao J; Bi X; He H; Shi X; Weng S; Chen Y; Yang Y; Ye Y; Fu G
J Mol Med (Berl); 2017 Feb; 95(2):155-165. PubMed ID: 27576917
[TBL] [Abstract][Full Text] [Related]
8. ROCK induced inflammation of the microcirculation during endotoxemia mediated by nitric oxide synthase.
McGown CC; Brown NJ; Hellewell PG; Brookes ZL
Microvasc Res; 2011 May; 81(3):281-8. PubMed ID: 21354186
[TBL] [Abstract][Full Text] [Related]
9. Sex-dependent differences in Rho activation contribute to contractile dysfunction in type 2 diabetic mice.
Nuno DW; Harrod JS; Lamping KG
Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1469-77. PubMed ID: 19666843
[TBL] [Abstract][Full Text] [Related]
10. Hydroxyl fasudil, an inhibitor of Rho signaling, improves erectile function in diabetic rats: a role for neuronal ROCK.
Sezen SF; Lagoda G; Musicki B; Burnett AL
J Sex Med; 2014 Sep; 11(9):2164-71. PubMed ID: 24919622
[TBL] [Abstract][Full Text] [Related]
11. Enhanced endothelin-1/Rho-kinase signalling and coronary microvascular dysfunction in hypertensive myocardial hypertrophy.
Tsai SH; Lu G; Xu X; Ren Y; Hein TW; Kuo L
Cardiovasc Res; 2017 Sep; 113(11):1329-1337. PubMed ID: 28575410
[TBL] [Abstract][Full Text] [Related]
12. RhoA/rock signaling mediates peroxynitrite-induced functional impairment of Rat coronary vessels.
Sun Z; Wu X; Li W; Peng H; Shen X; Ma L; Liu H; Li H
BMC Cardiovasc Disord; 2016 Oct; 16(1):193. PubMed ID: 27724862
[TBL] [Abstract][Full Text] [Related]
13. Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium.
Hamid SA; Bower HS; Baxter GF
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2598-606. PubMed ID: 17220176
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide does not downregulate Rho-kinase (ROCK-2) expression in rat coronary endothelial cells.
Tiftik RN; Erol A; Cnar MG; Kubat H; Ark M; Ulker S; Büyükafşar K
J Cardiovasc Pharmacol; 2008 Feb; 51(2):140-7. PubMed ID: 18287881
[TBL] [Abstract][Full Text] [Related]
15. Fasudil alleviates hepatic fibrosis in type 1 diabetic rats: involvement of the inflammation and RhoA/ROCK pathway.
Xie Y; Song T; Huo M; Zhang Y; Zhang YY; Ma ZH; Wang N; Zhang JP; Chu L
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5665-5677. PubMed ID: 30229844
[TBL] [Abstract][Full Text] [Related]
16. Chronic treatment with an oral rho-kinase inhibitor restores erectile function by suppressing corporal apoptosis in diabetic rats.
Li WJ; Park K; Paick JS; Kim SW
J Sex Med; 2011 Feb; 8(2):400-10. PubMed ID: 20233282
[TBL] [Abstract][Full Text] [Related]
17. Activated Rho kinase mediates diabetes-induced elevation of vascular arginase activation and contributes to impaired corpora cavernosa relaxation: possible involvement of p38 MAPK activation.
Toque HA; Nunes KP; Yao L; Liao JK; Webb RC; Caldwell RB; Caldwell RW
J Sex Med; 2013 Jun; 10(6):1502-15. PubMed ID: 23566117
[TBL] [Abstract][Full Text] [Related]
18. Role of Rho-kinase signaling and endothelial dysfunction in modulating blood flow distribution in pulmonary hypertension.
Schwenke DO; Pearson JT; Sonobe T; Ishibashi-Ueda H; Shimouchi A; Kangawa K; Umetani K; Shirai M
J Appl Physiol (1985); 2011 Apr; 110(4):901-8. PubMed ID: 21212241
[TBL] [Abstract][Full Text] [Related]
19. Rho-kinase inhibition improves vasodilator responsiveness during hyperinsulinemia in the metabolic syndrome.
Schinzari F; Tesauro M; Rovella V; Di Daniele N; Gentileschi P; Mores N; Campia U; Cardillo C
Am J Physiol Endocrinol Metab; 2012 Sep; 303(6):E806-11. PubMed ID: 22829585
[TBL] [Abstract][Full Text] [Related]
20. Fasudil inhibits the myogenic response in the fetal pulmonary circulation.
Tourneux P; Chester M; Grover T; Abman SH
Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1505-13. PubMed ID: 18676688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
